Stock ticker :
NYSE
DHR
AS OF
Jan 19, closing price
Price
$287.25
Change
-$1.33 (-0.46%)
Capitalization
$205.1b
DHR
Stock ticker :
NYSE
7 days until earnings call
Intraday data for
Jan 19, closing price
Price
$287.25
Change
-$1.33 (-0.46%)
Capitalization
$205.1b

(DHR) Stock Forecast and AI Recommendations

a manufacturer of industrial instruments and machinery
Industry MedicalSpecialties

Danaher Corp (DHR) Stock Stock Prediciton and Price Targets

Stock market charts, price targets, analyst ratings and a financial calendar
a manufacturer of industrial instruments and machinery
Industry MedicalSpecialties
A.I.dvisor published
a Summary for DHR with price predictions.
4:00 PM EST Jan 19

DHR sees MACD Histogram crosses below signal line

DHR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 04, 2022. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In 21 of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 45%.

Stock Forecast, Price, News, Quote

Current price $287.25 is below $313.77 the lowest support line found by A.I. Throughout the month of 12/16/21 - 01/19/22, the price experienced a -10% Downtrend. During the week of 01/11/22 - 01/19/22, the stock fell -6%.

Technical Analysis (Indicators)
Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 04, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on DHR as a result. In 33 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 40%.

DHR moved below its 50-day Moving Average on January 04, 2022 date and that indicates a change from an upward trend to a downward trend.

The 10-day Moving Average for DHR crossed bearishly below the 50-day moving average on January 11, 2022. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 27%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 37%.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where DHR advanced for three days, in 225 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

DHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.105) is normal, around the industry mean (9.167). P/E Ratio (36.900) is within average values for comparable stocks, (70.716). Projected Growth (PEG Ratio) (2.128) is also within normal values, averaging (4.210). Dividend Yield (0.003) settles around the average of (0.018) among similar stocks. P/S Ratio (7.502) is also within normal values, averaging (118.056).

The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. DHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

A.I.dvisor published
Danaher Corp Earnings Data

DHR is expected to report earnings to rise 5.02% to $2.51 per share on January 27

Danaher Corp DHR Stock Earnings Report
Q4'21
Est.
$2.51
Q3'21
Beat
by $0.24
Q2'21
Beat
by $0.41
Q1'21
Beat
by $0.76
Q4'20
Beat
by $0.20
The last earnings report on October 21 showed earnings per share of $2.39, beating the estimate of $2.15. With 2.97M shares outstanding, the current market capitalization sits at 205.11B.
A.I.dvisor found
Danaher Corp Dividends
DHR is expected to pay dividends on January 28, 2022
Danaher Corp DHR Stock Dividends
A dividend of $0.21 per share will be paid with a record date of January 28, 2022, and an ex-dividend date of December 29, 2021. The last dividend of $0.21 was paid on October 29. The ex-dividend date is usually set several business days before the record date. If a stock is purchased on its ex-dividend date or after, the next dividend payment will not be received. Instead, the dividends are repossessed by to the seller. If the stocks are purchased before the ex-dividend date, the buyer will receive the dividends.
A.I.dvisor
published General Information

General Information

Profile
Fundamentals
Details
Industry Medical Specialties
Address 2200 Pennsylvania Avenue, North West, Washington, DC, 20037-1701
Phone +1 202 828-0850
Employees 69000
Web https://www.danaher.com
DHR

Select Stock attributes to show

Capitalization 205B
P/E Ratio 36.90
Risk (Beta) 0.60
Dividend Yield 0.00
Total Cash 7.322B
Total Cash/Share 10.25
Total Debt 20.4B
Total Debt/Equity 12.90
Projected Growth (PEG Ratio) 2.13
Revenue/Share (as % of the share price) 38%
Revenue 26.7B
ROE N/A
Book Value 39.5B
P/B Ratio 5.10
Cash Flow N/A
Earnings 7.650
Average Daily Volume YTD N/A
Common Shares Outstanding - Security Level 9M
Current Ratio 2.26
Current Revenue Per Employee 104,608.70
Dividends Per Share - Security 0.21
EBITDA 8.986B
Float N/A
Float - Current N/A
Gross Income Margin 60.92
Revenue To Assets 7.30
Shares Held By Institutions 1.828T
Shares Outstanding - Current N/A
Total Liabilities 35.3B
Total Volume MTD N/A
Value Under
Gain YTD -12.759
Group Domestic Stock Funds
Category Medical Specialties
Total Expense Ratio
Min. Initial Investment 0.00 USD
Fund Existence
Turnover
Front Load
Net Assets 0.00 USD
Manager Tenure
Group Domestic Stock Funds
Category Medical Specialties
Capitalization 205.11b USD
P/E Ratio 36.900368
Total Cash 7.32b USD
Projected Growth 2.13
Total Debt 20.42b USD
Revenue 26.72b USD
Risk (Beta) 0.60
Dividend Yield 0.00
Total Cash/Share 10.25
Total Debt/Equity 12.9
Revenue/Share 38.00USD as % of share price
Group Domestic Stock Funds
Category Medical Specialties
Net Assets 0.00 USD
Fund Existence
Turnover
Capitalization
Yield
Total Expense Ratio
Investment Style
Risk (Beta)
Group Domestic Stock Funds
Category Medical Specialties
Market Capitalization 0.00 USD
Volume 0.00 USD